Literature DB >> 16425386

Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis.

Mika Yamamoto1, Motoh Iwasa, Kaname Matsumura, Yuri Nakagawa, Naoki Fujita, Yoshinao Kobayashi, Masahiko Kaito, Kan Takeda, Yukihiko Adachi.   

Abstract

AIM: To evaluate the effect of oral intake of branched-chain amino acids (BCAA) on brain perfusion in patients with liver cirrhosis.
METHODS: Single photon emission computed tomography scans were performed in 43 patients with cirrhosis and in 15 age-matched healthy subjects. Twenty-nine out of forty-three patients were randomly treated with either BCAA granules or placebo, and single photon emission computed tomography was performed before and after the treatment. We measured the regional cerebral blood flow values using a three-dimensional stereotaxic region of interest template.
RESULTS: Cirrhotic patients had regions of significant hypoperfusion in the bilateral central (right P=0.039, P<0.05; left P=0.006 P<0.01), parietal (right P=0.018, P<0.05; left P=0.009, P<0.01), angular (right P=0.039, P<0.05; left P 0.008, P<0.01), and left pericallosal segments (P=0.038 P<0.05) as compared with healthy subjects. A significant increase in cerebral perfusion was observed 70 min after the oral intake of BCAA in the angular (right P=0.012, P<0.05; left P=0.049, P<0.05), temporal (right P=0.012, P<0.05; left P=0.038, P<0.05), pericallosal segments (right P=0.025, P<0.05; left P=0.049, P<0.05) and left precentral (P=0.044, P<0.05), parietal (P=0.040, P<0.05) and thalamus (P=0.033, P<0.05). No significant change in perfusion was observed in the placebo group.
CONCLUSION: Administration of BCAA rapidly improves cerebral perfusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16425386      PMCID: PMC4725045          DOI: 10.3748/wjg.v11.i43.6792

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.

Authors:  Björn Ahl; Karin Weissenborn; Jörg van den Hoff; Daniela Fischer-Wasels; Herbert Köstler; Hartmut Hecker; Wolfgang Burchert
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

2.  Leucine oxidation in brain slices and nerve endings.

Authors:  E R Chaplin; A L Goldberg; I Diamond
Journal:  J Neurochem       Date:  1976-04       Impact factor: 5.372

Review 3.  Topography of cognition: parallel distributed networks in primate association cortex.

Authors:  P S Goldman-Rakic
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

4.  SPECT scan and cognitive findings in subclinical hepatic encephalopathy.

Authors:  P T Trzepacz; R E Tarter; A Shah; R Tringali; D G Faett; D H Van Thiel
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1994       Impact factor: 2.198

5.  Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy.

Authors:  A M Catafau; J Kulisevsky; L Bernà; J Pujol; J C Martin; P Otermin; J Balanzó; I Carrió
Journal:  J Nucl Med       Date:  2000-03       Impact factor: 10.057

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 7.  Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.

Authors:  F Rossi Fanelli; C Cangiano; L Capocaccia; A Cascino; F Ceci; M Muscaritoli; G Giunchi
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

8.  Cerebral blood flow SPET in transient global amnesia with automated ROI analysis by 3DSRT.

Authors:  Ryo Takeuchi; Hiroshi Matsuda; Katsunori Yoshioka; Yoshiharu Yonekura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

9.  Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation.

Authors:  M Dam; P Burra; U Tedeschi; A Cagnin; F Chierichetti; M Ermani; G Ferlin; R Naccarato; G Pizzolato
Journal:  J Hepatol       Date:  1998-07       Impact factor: 25.083

10.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

View more
  8 in total

Review 1.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  The treatment of hepatic encephalopathy.

Authors:  Marsha Y Morgan; A Blei; K Grüngreiff; R Jalan; G Kircheis; G Marchesini; O Riggio; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

3.  Brain perfusion single photon emission computed tomography abnormalities in patients with minimal hepatic encephalopathy.

Authors:  Hejjaji Venkataramarao Sunil; Bhagwant Rai Mittal; Roshan Kurmi; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 4.  When can nutritional therapy impact liver disease?

Authors:  Matthew C Bozeman; Matthew V Benns; Stephen A McClave; Keith R Miller; Christopher M Jones
Journal:  Curr Gastroenterol Rep       Date:  2014-10

Review 5.  Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases.

Authors:  Han Ah Lee; Young Chang; Pil Soo Sung; Eileen L Yoon; Hye Won Lee; Jeong-Ju Yoo; Young-Sun Lee; Jihyun An; Do Seon Song; Young Youn Cho; Seung Up Kim; Yoon Jun Kim
Journal:  Clin Mol Hepatol       Date:  2022-07-01

6.  Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis.

Authors:  Andrea N Edginton; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study.

Authors:  Yumiko Nagao; Takumi Kawaguchi; Tatsuya Ide; Michio Sata
Journal:  Virol J       Date:  2012-11-22       Impact factor: 4.099

8.  Which of the branched-chain amino acids increases cerebral blood flow in hepatic encephalopathy? A double-blind randomized trial.

Authors:  Fernando Gomes Romeiro; Marjorie do Val Ietsugu; Letícia de Campos Franzoni; Laís Augusti; Matheus Alvarez; Lívia Alves Amaral Santos; Talles Bazeia Lima; Kátia Hiromoto Koga; Sônia Marta Moriguchi; Carlos Antonio Caramori; Giovanni Faria Silva; Luiz Eduardo Gomes Garcia Betting
Journal:  Neuroimage Clin       Date:  2018-03-28       Impact factor: 4.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.